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Background
Lafora Disease (LD) is a fatal teenage-onset progressive
myoclonus epilepsy. It is characterized by the formation
of Lafora bodies (LBs), deposits of abnormally branched,
insoluble, hyperphosphorylated glycogen-like polymers
that are generally believed to trigger the development of
the clinical symptoms of LD. 58% and 35% of the LD
cases are caused by mutations in EPM2A (laforin) and
EPM2B (malin), respectively. However, little is known
about their function in LB formation. Two different
mechanisms have been proposed to explain the accumu-
lation of insoluble LBs: first, excessive glycogen phos-
phorylation and, second, an imbalance between glycogen
synthesizing enzymes. The present study aims at the
identification of proteins involved in the molecular
mechanisms leading to LB formation and appearance of
LD and the phosphorylation of glycogen.
Materials and methods
Isolation of native LBs is a prerequisite for proteomic
analysis of proteins associated with LBs. Therefore, a
workflow has been established for the isolation of native
LBs from different tissues. Here, we show the analysis of
brain, heart and skeletal muscle tissue from 9-month-old
EPM2A-/- mice. Successful purification of the inclusion
bodies was demonstrated by light microscopy after PAS
and iodine staining and by electron microscopy. Peptides
for analysis on a LTQ Orbitrap Velos were generated by
In-solution tryptic digestion of proteins attached to the
isolated bodies. To allow for a semi-quantitative analysis,
wild-type tissues were prepared in parallel and used as
controls. Each experiment was performed with two bio-
logical and two technical replicates.
Results
Using the established workflow we isolated native LBs of
variable sizes and shapes from brain, heart and skeletal
muscle of EPM2A-/- mice. The semi-quantitative analy-
sis resulted in the identification of 90 proteins that were
highly upregulated in knockout tissues or not detectable
in the wild type. Many of these are well-known proteins
involved in glycogen metabolism indicating the signifi-
cance of our study. However, we also identified a number
of interesting candidates potentially or de facto involved
in disease related processes, such as autophagy.
Conclusions
We established the first workflow for the isolation of
native LBs allowing for a subsequent proteomic analysis
of associated proteins. Using this method, we identified
known glycogen-related proteins together with new can-
didates putatively involved in LB formation and LD
establishment representing potential targets for future
therapeutic approaches.
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